TDX (R) DIGOXIN NXT— 510(k) K882233

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K882233 for TDX (R) DIGOXIN NXT, Substantially Equivalent on 1988-07-06. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code KXT
Advisory panel: Clinical Toxicology
Date received: 1988-05-27
Decision date: 1988-07-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.